17β-Estradiol Attenuates Hypoxic Pulmonary Hypertension via Estrogen Receptor–mediated Effects

Rationale: 17β-Estradiol (E2) attenuates hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension (HPH) through an unknown mechanism that may involve estrogen receptors (ER) or E2 conversion to catecholestradiols and methoxyestradiols with previously unrecognized effects on cardiopulmon...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lahm, Tim, Albrecht, Marjorie, Fisher, Amanda J., Selej, Mona, Patel, Neel G., Brown, Jordan A., Justice, Matthew J., Brown, M. Beth, Van Demark, Mary, Trulock, Kevin M., Dieudonne, Dino, Reddy, Jagadeshwar G., Presson, Robert G., Petrache, Irina
Format: Artigo
Idioma:Inglês
Publicat: American Thoracic Society 2012
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359941/
https://ncbi.nlm.nih.gov/pubmed/22383500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201107-1293OC
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars